Navigation Links
InteKrin Therapeutics to Present Phase 2b Clinical Data for Edema at the 2010 American Diabetes Association Annual Meeting
Date:6/18/2010

LOS ALTOS, Calif., June 18 /PRNewswire/ -- InteKrin Therapeutics Inc. announced today it will present 6 month Phase 2b clinical data for edema in diabetic patients showing differentiation for INT131, a Selective PPAR-gamma Modulator (SPPARM), from Actos® pioglitazone, at the American Diabetes Association annual meeting in Orlando, FL, Monday, June 28, 2010 at 2:45 pm EDT during the "Update on BARI 2D --Treatment of Insulin Resistance" session.

Dr. Alex DePaoli, Acting Chief Medical Officer of InteKrin Therapeutics, will present "INT131 Besylate, a Selective PPAR-gamma Modulator (SPPARM), Improved Glycemic Control in Patients with Type 2 Diabetes without Causing the Edema Seen with Pioglitazone."

About INT131

INT131 is a next-generation insulin sensitizer that addresses insulin resistance, a key etiological feature in the onset and subsequent progression of Type 2 Diabetes.  As a selective PPAR-gamma modulator (SPPARM), INT131 has been designed to provide potent glucose lowering and durability of effect without the recognized side effects of the currently available insulin sensitizers which, unlike INT131, are full PPAR-gamma agonists. InteKrin has completed an End-Of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) for INT131 and is moving the program into Phase 3 development.

About InteKrin (www.InteKrin.com)

InteKrin Therapeutics is a privately-held clinic
'/>"/>

SOURCE InteKrin Therapeutics Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. InteKrin Therapeutics Announces Initiation of Phase 2b Study in Type 2 Diabetes with INT131
2. InteKrin Therapeutics Announces Enrollment Completion of 360 Patient, 24 week Phase 2b Study
3. InteKrin Therapeutics to Present at the 2009 American Diabetes Association Annual Meeting
4. InteKrin Therapeutics Presents Positive Long Term INT131 Preclinical Cardiovascular Safety Data at the 45th Annual European Association for the Study of Diabetes Meeting
5. InteKrin Therapeutics Co-Founder Receives Appointment as Professor of Medicine at Harvard Medical School
6. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
7. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
8. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
9. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
10. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
11. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... PUNE, India , September 4, 2015 ... "Apheresis Market by Application (Plasmapheresis, Plateletpheresis, Erythrocytapheresis, Leukapheresis, and ... by Technology and by Product - Global Forecast to ... expected to reach USD 2.5 Billion by 2020, growing ... from 2015 to 2020. Browse 139 ...
(Date:9/4/2015)... NEW YORK , Sept. 4, 2015  Cumberland ... Executive Officer, will present live at VirtualInvestorConferences.com on September ... TIME: 2:30p.m. ET LINK: http://tinyurl.com/sep10pre ... online event where investors are invited to ask the ... hall as well as the association,s "virtual trade booth." ...
(Date:9/4/2015)... DUBLIN , Sept. 4, 2015  Allergan plc (NYSE: ... that Brent Saunders , CEO and President of Allergan, ... at the Morgan Stanley Global Healthcare Conference 2015 in ... http://photos.prnewswire.com/prnh/20150612/222796LOGO The presentation will take ... Time at the Grand Hyatt New York, 109 East 42nd ...
Breaking Medicine Technology:Apheresis Market Worth 2.5 Billion USD by 2020 2Apheresis Market Worth 2.5 Billion USD by 2020 3Apheresis Market Worth 2.5 Billion USD by 2020 4Apheresis Market Worth 2.5 Billion USD by 2020 5Cumberland Pharmaceuticals to Webcast, Live, at VirtualInvestorConferences.com September 10 2Allergan to Present at Morgan Stanley Global Healthcare Conference 2015 2Allergan to Present at Morgan Stanley Global Healthcare Conference 2015 3
... experts recommend annual influenza vaccination for nearly 250 million ... rates fall far short every year. According to the ... 28,842 to 115,368 Denver residents will suffer from influenza ... immunization, the American Lung Association in Colorado (ALAC) is ...
... Oct. 15 Savient Pharmaceuticals, Inc. (Nasdaq: SVNT ... underwritten public offering. Prior to closing, the underwriters exercised ... shares of common stock. As a result, Savient sold ... at a price to the public of $13.29 per ...
Cached Medicine Technology:American Lung Association in Colorado's Faces of Influenza Initiative Rolls Up its Sleeves to Kick Off Flu Season in Denver 2American Lung Association in Colorado's Faces of Influenza Initiative Rolls Up its Sleeves to Kick Off Flu Season in Denver 3American Lung Association in Colorado's Faces of Influenza Initiative Rolls Up its Sleeves to Kick Off Flu Season in Denver 4Savient Pharmaceuticals Announces Closing of Public Offering and Exercise of Over-Allotment Option 2
(Date:9/4/2015)... ... ... and Overseer at The House of Yahweh, has written an open letter to Pope Francis ... United States. , Yisrayl lays out what he says is the true meaning of the ... provides the meaning of his own name and describes what bible prophecy says about his ...
(Date:9/4/2015)... , ... September 04, 2015 , ... Friday night, Chicago ... hosting Generation Rescue’s A Night of Hope event supporting families affected by autism, raising ... Rowena and Joe Salas, joined together at the Oscar Swan Inn to support the ...
(Date:9/3/2015)... ... September 03, 2015 , ... Allied Anesthesia is proud to announce ... the norm not the exception. , St. Jude was recently named one of the ... Association, making it one of only 10 hospitals in the state to earn the ...
(Date:9/3/2015)... ... September 03, 2015 , ... William Mattar Law Offices is known for ... does not stop at any certain demographic or segment of the population. Because ... fifteen- and ten-second TV commercials. , The closed captioning will allow people with hearing ...
(Date:9/3/2015)... ... 2015 , ... The Beryl Institute announces 52 breakout sessions ... April 13-15 at Sheraton Hotel in Dallas, Texas. Patient Experience Conference is the ... healthcare leaders, staff, physicians, patients and families across the globe to convene, engage ...
Breaking Medicine News(10 mins):Health News:Yisrayl Hawkins Writes Open Letter to Pope Francis In Light of Approaching U.S. Visit 2Health News:Jenny McCarthy & Donnie Wahlberg Help Raise Over $200,000 For Generation Rescue’s ‘Night Of Hope’ Chicago Charity Event 2Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 2Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 3Health News:Law Firm Focused on “Helping People” Continues to Expand on Vision 2Health News:Patient Experience Conference 2016 Program Announced by The Beryl Institute 2Health News:Patient Experience Conference 2016 Program Announced by The Beryl Institute 3
... dengue fever in the state has been brought out ... aegypti, mosquito is the common carrier of both chikungunya ... has taken up an integrated mosquito control programme involving ... areas in every house will be examined. ...
... proteins in the eye is the main trigger for ... researchers at Case Western Reserve University and the Cleveland ... one of the main reasons for the development of ... among people over 65 in the United States. ...
... depression and falls all increase risk of developing a ... a particularly effective way to reduce the nation’s disability ... efforts that combine education about risks with exercise, home ... least in the short run, found researchers led by ...
... an insight into how effective the lead petrol ban has ... of the otters killed by cars //since 1992 has found ... a valuable pointer for human health as well since lead ... well as affect the kidney. ,Researcher Dr. Liz ...
... Inc., confirms their plans to go into a partnership ... journal.// ,International publisher John Wiley & Sons, ... plans of a new agreement with the North American ... the American Association for the Study of Liver Diseases ...
... and uncertainty as a part of it. However, the ... of nuclear power stations and flu pandemic// has generated ... do something to re-build trust in politicians and scientists. ... risk originates from emotions and not logic, particularly, when ...
Cached Medicine News:Health News:Molecule responsible for age associated macular degeneration identified 2Health News:Preventing Falls May Be Key to Avoiding Disability in Elderly 2Health News:Danger and insecurity in contemporary life 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: